LVMH boss Bernard Arnault under investigation in Paris over Russian oligarch transactions

Wealth

Bernard Arnault, Chairman and CEO of LVMH Moet Hennessy Louis Vuitton, attends a news conference to present the 2022 annual results of LVMH in Paris, France, January 26, 2023.
Gonzalo Fuentes | Reuters

The Paris public prosecutor’s office is investigating LVMH CEO Bernard Arnault over financial transactions involving Russian oligarch Nikolai Sarkisov.

French newspaper Le Monde reported Thursday, citing France’s Tracfin financial intelligence unit, that Sarkisov had bought real estate at an Alpine resort with the help of a loan from Arnault.

The Paris prosecutor’s office confirmed Friday that a preliminary investigation had been underway since 2022, and that a Tracfin report “drawing the attention of the prosecutor’s office to operations concerning Mr. Bernard Arnault and Mr. Sarkisov, likely to characterize acts of money laundering, has been attached to this procedure.”

The prosecutor’s office declined to comment further on the ongoing investigations. A preliminary investigation does not necessarily imply wrongdoing, and Le Monde cited a close associate of Arnault as saying the deal was carried out within the scope of French law.

Arnault, the founder, CEO and chairman of the world’s largest luxury goods company and one of the world’s richest men, lost a high court case against French tax investigators in February over the legality of a 2019 raid on LVMH’s headquarters. The raid related to a tax fraud probe linked to activities in Belgium.

Nikolai Sarkisov is a senior figure at his brother Sergei’s Russian insurance company, RESO-Garantiya.

LVMH and RESO-Garantiya did not respond to CNBC requests for comment.

Articles You May Like

Ex-Spousal Benefits: What ‘Independently Entitled’ Means
Medicare Premiums For 2025 Rise 5.9%, Other Out-Of-Pocket Costs Increase
Space stocks saw big gains this week in part due to ‘Trump-Elon trade’ rally, analysts say
Target shares plunge 20% after discounter cuts forecast, posts biggest earnings miss in two years
The Medicare Prescription Payment Plan: Yay Or Nay?

Leave a Reply

Your email address will not be published. Required fields are marked *